These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11243115)

  • 1. [Progress in the study of autologous hematopoietic stem cell transplantation therapy of multiple myeloma].
    Zhang M; Son K
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):331-3. PubMed ID: 11243115
    [No Abstract]   [Full Text] [Related]  

  • 2. [The intensive treatment of multiple myeloma with support from hematopoietic progenitors].
    Paz-Ares L; Lahuerta J; Montes A
    Med Clin (Barc); 1997 Feb; 108(6):226-9. PubMed ID: 9102490
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.
    Hahn T; Wingard JR; Anderson KC; Bensinger WI; Berenson JR; Brozeit G; Carver JR; Kyle RA; McCarthy PL
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):4-37. PubMed ID: 12533739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    López-Pérez R; García-Sanz R; González D; Balanzategui A; Chillón MC; Alaejos I; Mateos MV; Caballero MD; Corral M; Orfão A; González M; San Miguel JF
    Bone Marrow Transplant; 2001 Oct; 28(7):665-72. PubMed ID: 11704789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The importance of autologous transplantation in multiple myeloma].
    Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex-vivo purging of hematopoietic progenitor cells.
    de Lima M; Shpall EJ
    Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandem bone marrow transplantation in multiple myeloma.
    Musto P
    N Engl J Med; 2004 Apr; 350(14):1466-7; author reply 1466-7. PubMed ID: 15074004
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of autologous stem-cell transplantation in multiple myeloma.
    Attal M; Harousseau JL
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):747-59. PubMed ID: 18070717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tandem bone marrow transplantation in multiple myeloma.
    Chng WJ
    N Engl J Med; 2004 Apr; 350(14):1466-7; author reply 1466-7. PubMed ID: 15074003
    [No Abstract]   [Full Text] [Related]  

  • 10. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.
    Pitini V; Arrigo C; Aloi G; Micali C; La Gattuta G
    Bone Marrow Transplant; 2003 Jun; 31(11):1065; author reply 1067. PubMed ID: 12774062
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation in multiple myeloma.
    Pant S; Copelan EA
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):877-85. PubMed ID: 17640590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High-dosage chemotherapy with support of autologous haematopoietic cells in the treatment of multiple myeloma--review of contemporary possibilities].
    Rácil Z; Adam Z; Hájek R; Tomíska M; Krejcí M; Krivanová A; Höklová J; Doubek M; Mayer J; Vorlícek J
    Vnitr Lek; 2001 Feb; 47(2):92-8. PubMed ID: 15635853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted treatments to improve stem cell outcome: old and new drugs.
    Raab MS; Breitkreutz I; Anderson KC
    Bone Marrow Transplant; 2007 Dec; 40(12):1129-37. PubMed ID: 17768392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma--an update on diagnosis and treatment.
    Caers J; Vande broek I; De Raeve H; Michaux L; Trullemans F; Schots R; Van Camp B; Vanderkerken K
    Eur J Haematol; 2008 Nov; 81(5):329-43. PubMed ID: 18637123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances in the study of autologous hematopoietic stem cell purging].
    Wu SK; Lin C; Song ST
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):65-8. PubMed ID: 15946540
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hematopoietic stem cell transplantation in multiple myeloma].
    Vela-Ojeda J; Ruiz-Esparza MA
    Rev Invest Clin; 2005; 57(2):305-13. PubMed ID: 16524072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma].
    García Laraña J; Díaz Mediavilla J; Martínez R; Lahuerta JJ; Alegre A; Odriozola J; Sureda A; San Miguel J; De la Rubia J; Escudero A; Conde E; Bladé J; Cabrera R; Gastearena J; Besalduch J; Vidal MJ; Hernández F; Rifon J; Leon A; Mataix R; Parody R; Moraleda JM; Solano C; de Pablos JM; Sánchez JJ
    Sangre (Barc); 1997 Apr; 42 Suppl 1():38-41. PubMed ID: 9381300
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hematopoietic stem cell transplantation in multiple myeloma].
    Okamoto S
    Nihon Naika Gakkai Zasshi; 1995 Jul; 84(7):1127-31. PubMed ID: 7561371
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
    Alici E; Björkstrand B; Treschow A; Aints A; Smith CI; Gahrton G; Dilber MS
    Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation.
    Patriarca F; Prosdocimo S; Tomadini V; Vasciaveo A; Bruno B; Fanin R
    Haematologica; 2005 Feb; 90(2):278-9. PubMed ID: 15710593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.